Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arralyze is a life sciences technology company that provides an integrated platform for single-cell analysis and cell-based assays. The company's flagship product, CellShepherd, utilizes glass-based nanowell arrays and high-precision liquid handling to enable the isolation, cultivation, and monitoring of individual cells in real-time. This technology is designed to accelerate workflows in antibody discovery, cell line development, and synthetic biology by providing high-throughput screening with single-cell resolution. Arralyze operates as a specialized business unit of LPKF Laser & Electronics SE, leveraging advanced laser glass processing capabilities to offer superior optical quality for imaging. The platform is particularly suited for researchers looking to automate complex biological protocols at the single-cell level.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arralyze.